Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Internal Region) Peptid
SPG20
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle SPG20 Produkte
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Protein-Typ
- Synthetic
- Protein Region
- Internal Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- SPARTIN peptide is a synthetic peptide cooresponding to 15 amino acids from an internal region of SPARTIN.
-
-
- Applikationshinweise
- SPARTIN Peptide is used for blocking the activity of SPARTIN antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- SPARTIN peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 ?L water, the concentration will be 0.5 mg/mL.
- Handhabung
- When reconstituted minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C.
-
- Target
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Synonyme
- SPARTIN Peptide, TAHCCP1 Peptide, AI840044 Peptide, C79168 Peptide, mKIAA0610 Peptide, spartin Peptide, Spg20 Peptide, spg20a Peptide, zgc:172059 Peptide, spg20b Peptide, zgc:153766 Peptide, spartin Peptide, spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) Peptide, spartin a Peptide, spartin b Peptide, SPART Peptide, Spg20 Peptide, Spart Peptide, sparta Peptide, spartb Peptide
- Gen-ID
- 23111
- NCBI Accession
- NP_005682, NP_064693
- UniProt
- Q8N0X7
-
Sie sind hier:
